SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-15-002119
Filing Date
2015-04-23
Accepted
2015-04-22 19:06:25
Documents
2
Period of Report
2015-04-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FILING DOCUMENT document.htm 8-K 6248
2 PRESS RELEASE newsrelease.htm EX-99 3613
  Complete submission text file 0001171843-15-002119.txt   11009
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34949 | Film No.: 15786624
SIC: 2834 Pharmaceutical Preparations